Abstract Deadline: Dec. 31
In its fall issue, Cancer Today profiles colon cancer survivor and school counselor Diane Nathaniel.
Honoring distinguished scientists
Combining Endocrine Therapy with a CDK4/6 Inhibitor Results In Similar Response Rates to Chemotherapy for High-Risk Luminal B Breast Cancer
New HER2 Antibody-drug Conjugate Yielded Promising Clinical Responses in Breast Cancer Patients Pretreated with T-DM1
Updated APHINITY Trial Data Show Addition of Pertuzumab to Trastuzumab Plus Chemotherapy Continues to Yield Clinical Benefit in Patients With Operable HER2-positive Early Breast Cancer
AACR Breast Cancer Research Fellowships
AACR-Novocure Career Development Awards for Tumor Treating Fields Research
AACR-Novocure Tumor Treating Fields Research Grants
The Microbiome, Viruses, and Cancer
